• Sangamo Therapeutics (NASDAQ:SGMO) Earns "Buy" Rating from HC Wainwright

    المصدر: Buzz FX / 27 يناير 2025 08:55:18   America/New_York


    Sangamo Therapeutics (NASDAQ:SGMO) Earns "Buy" Rating from HC Wainwright Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Sangamo Therapeutics ( NASDAQ:SGMO - Get Free Report ) 's stock had its "buy" rating restated by
    Read more...
شارك على،